Alkermes (ALKS) PT Raised to $32 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Buildings collapse as quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Cantor Fitzgerald Reiterates Overweight Rating on Alkermes (ALKS)
February 13, 2025 9:28 AM ESTCantor Fitzgerald analyst Dr Charles Duncan reiterated an Overweight rating and $43.00 price target on Alkermes (NASDAQ: ALKS).
He said, "Trading at EV/FY25 sales = 3.7x, we believe ALKS shares remain compelling as a differentiated core holding for patient investors in front of... More
Alkermes (ALKS) PT Raised to $38 at TD Cowen
February 13, 2025 8:36 AM ESTTD Cowen analyst Joseph Thome raised the price target on Alkermes (NASDAQ: ALKS) to $38.00 (from $35.00) while maintaining a Buy rating.... More
Jefferies Reiterates Buy Rating on Alkermes (ALKS)
February 12, 2025 1:18 PM ESTJefferies analyst Akash Tewari reiterated a Buy rating and $41.00 price target on Alkermes (NASDAQ: ALKS).
The analyst comments "ALKS reported a beat in Q4 on both total revs ($430M vs $356M cons) & non-GAAP EPS ($1.04 vs $0.72 cons) - Lybalvi revs were $77M... More
Alkermes (ALKS) Tops Q4 EPS by 30c
February 12, 2025 7:01 AM ESTAlkermes (NASDAQ: ALKS) reported Q4 EPS of $1.05, $0.30 better than the analyst estimate of $0.75. Revenue for the quarter came in at $430 million versus the consensus estimate of $380.75 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
... MoreDeutsche Bank Starts Alkermes (ALKS) at Buy
February 11, 2025 4:11 AM ESTDeutsche Bank analyst David Hoang initiates coverage on Alkermes (NASDAQ: ALKS) with a Buy rating and a price target of $40.00.
The analyst comments: "ALKS shares have been largely rangebound over the past year, but we believe the company has a potential best-in-class orexin receptor... More
